Ovidiu C Andronesi
Overview
Explore the profile of Ovidiu C Andronesi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
2158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weiser P, Weiser P, Langs G, Bogner W, Motyka S, Strasser B, et al.
Neuroimage
. 2025 Feb;
309:121045.
PMID: 39894238
Introduction: Altered neurometabolism is an important pathological mechanism in many neurological diseases and brain cancer, which can be mapped non-invasively by Magnetic Resonance Spectroscopic Imaging (MRSI). Advanced MRSI using non-cartesian...
2.
Weiser P, Langs G, Motyka S, Bogner W, Courvoisier S, Hoffmann M, et al.
Magn Reson Med
. 2024 Dec;
93(4):1430-1442.
PMID: 39737778
Purpose: Proton magnetic resonance spectroscopic imaging ( -MRSI) provides noninvasive spectral-spatial mapping of metabolism. However, long-standing problems in whole-brain -MRSI are spectral overlap of metabolite peaks with large lipid signal...
3.
Klauser A, Strasser B, Bogner W, Hingerl L, Courvoisier S, Schirda C, et al.
Imaging Neurosci (Camb)
. 2024 Dec;
2:1-20.
PMID: 39679200
A novel method for fast and high-resolution metabolic imaging, called ECcentric Circle ENcoding TRajectorIes for Compressed sensing (ECCENTRIC), has been developed at 7 Tesla MRI. ECCENTRIC is a non-Cartesian spatial-spectral...
4.
Blomer S, Hingerl L, Marjanska M, Bogner W, Motyka S, Hangel G, et al.
Magn Reson Med
. 2024 Nov;
93(4):1443-1457.
PMID: 39568225
Purpose: Proton (H)-MRSI via spatial-spectral encoding poses high demands on gradient hardware at ultra-high fields and high-resolutions. Rosette trajectories help alleviate these problems, but at reduced SNR-efficiency because of their...
5.
Baboli M, Wang F, Dong Z, Dietrich J, Uhlmann E, Batchelor T, et al.
Radiology
. 2024 Sep;
312(3):e232401.
PMID: 39315894
Background: MR spectroscopic imaging (MRSI) can be used to quantify an extended brain metabolic profile but is confounded by changes in tissue water levels due to disease. Purpose: To develop...
6.
Blomer S, Hingerl L, Marjanska M, Bogner W, Motyka S, Hangel G, et al.
medRxiv
. 2024 Apr;
PMID: 38645249
Purpose: 1.1 Proton ( H)-MRSI via spatial-spectral encoding poses high demands on gradient hardware at ultra-high fields and high-resolutions. Rosette trajectories help alleviate these problems, but at reduced SNR-efficiency due...
7.
Klauser A, Strasser B, Bogner W, Hingerl L, Courvoisier S, Schirda C, et al.
ArXiv
. 2023 Jun;
PMID: 37292485
A novel method for fast and high-resolution metabolic imaging, called ECcentric Circle ENcoding TRajectorIes for Compressed sensing (ECCENTRIC), has been developed and implemented at 7 Tesla MRI. ECCENTRIC is a...
8.
Li X, Strasser B, Neuberger U, Vollmuth P, Bendszus M, Wick W, et al.
Neurooncol Adv
. 2022 Aug;
4(1):vdac071.
PMID: 35911635
Background: Magnetic resonance spectroscopic imaging (MRSI) can be used in glioma patients to map the metabolic alterations associated with mutations that are central criteria for glioma diagnosis. The aim of...
9.
Thapa B, Mareyam A, Stockmann J, Strasser B, Keil B, Hoecht P, et al.
J Magn Reson Imaging
. 2021 Dec;
56(1):121-133.
PMID: 34958166
Background: Absolute quantification of metabolites in MR spectroscopic imaging (MRSI) requires a stable reference signal of known concentration. The Electronic REference To access In vivo Concentrations (ERETIC) has shown great...
10.
Strasser B, Arango N, Stockmann J, Gagoski B, Thapa B, Li X, et al.
NMR Biomed
. 2021 Oct;
35(1):e4621.
PMID: 34609036
MR spectroscopic imaging (MRSI) noninvasively maps the metabolism of human brains. In particular, the imaging of D-2-hydroxyglutarate (2HG) produced by glioma isocitrate dehydrogenase (IDH) mutations has become a key application...